https://www.marketscreener.com/quote/stock/REXAHN-PHARMACEUTICALS-IN-3064379/news/Rexahn-Pharmaceuticals-Provides-Update-on-Phase-I-Supinoxin-Trial-in-Cancer-Patients-with-Solid-Tu-18761046/?utm_source=telegram&utm_medium=social&utm_campaign=share